Clinical Trial: A Study to Evaluate the Efficacy and Safety of CIN-102 (deudomperidone) in Adult Subjects with Idiopathic Gastroparesis.

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06899217) titled 'A Study to Evaluate the Efficacy and Safety of CIN-102 (deudomperidone) in Adult Subjects with Idiopathic Gastroparesis.' on Feb. 14.

Brief Summary: The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopathic gastroparesis severity in adult subjects.

The main questions it aims to answer are:

* To evaluate the efficacy of CIN-102 on symptoms of gastroparesis when given to patients with idiopathic gastroparesis compared to a placebo

* To evaluate the safety of CIN-102 when given to patients with idiopathic gastroparesis compared to a plac...